Low-dose rituximab in autoimmune hemolytic anemia: 10 years after

Low-dose rituximab in autoimmune hemolytic anemia: 10 years after

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2019-02, Vol.133 (9), p.996-998
Hauptverfasser: Fattizzo, Bruno, Zaninoni, Anna, Pettine, Loredana, Cavallaro, Francesca, Di Bona, Eros, Barcellini, Wilma
Format: Artikel
Sprache:eng
Schlagworte:
Anemia, Hemolytic, Autoimmune
Antibodies, Monoclonal, Murine-Derived
Humans
Rituximab
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 998
container_issue 9
container_start_page 996
container_title Blood
container_volume 133
creator Fattizzo, Bruno
Zaninoni, Anna
Pettine, Loredana
Cavallaro, Francesca
Di Bona, Eros
Barcellini, Wilma
description
doi_str_mv 10.1182/blood-2018-12-885228
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2179440034</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497120427545</els_id><sourcerecordid>2179440034</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-8d7b0f5867a66485d887d52c5c35f4eec69e5c0dc10af118fb5fec883388f8d43</originalsourceid><addsrcrecordid>eNp9kMFO3DAQhi0EYpeFN6iqHLmYjh07me2hEkJAK63UC5wtxx4LV8ma2knLvj3ZLuXIaS7fzD__x9gnAVdCoPzS9Sl5LkEgF5IjainxiC2FlsgBJByzJQA0XK1bsWBnpfwCEKqW-pQtamhaUAqW7HqT_nKfClU5jtNLHGxXxW1lpzHFYZi2VD3RkPrdGF1ltzRE-7USUO3I5lLZMFI-ZyfB9oUu3uaKPd7dPtx855uf9z9urjfcKcCRo287CBqb1jaNQu0RW6-l067WQRG5Zk3agXcCbJgLhk4Hcoh1jRjQq3rFLg93n3P6PVEZzRCLo76f30pTMVK067kS1HtUHVCXUymZgnnOc7O8MwLMXp75J8_s5RkhzUHevPb5LWHqBvLvS_9tzcC3A0Bzzz-Rsiku0taRj5ncaHyKHye8At1uf-o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2179440034</pqid></control><display><type>article</type><title>Low-dose rituximab in autoimmune hemolytic anemia: 10 years after</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Fattizzo, Bruno ; Zaninoni, Anna ; Pettine, Loredana ; Cavallaro, Francesca ; Di Bona, Eros ; Barcellini, Wilma</creator><creatorcontrib>Fattizzo, Bruno ; Zaninoni, Anna ; Pettine, Loredana ; Cavallaro, Francesca ; Di Bona, Eros ; Barcellini, Wilma</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2018-12-885228</identifier><identifier>PMID: 30670440</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Anemia, Hemolytic, Autoimmune ; Antibodies, Monoclonal, Murine-Derived ; Humans ; Rituximab</subject><ispartof>Blood, 2019-02, Vol.133 (9), p.996-998</ispartof><rights>2019 American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-8d7b0f5867a66485d887d52c5c35f4eec69e5c0dc10af118fb5fec883388f8d43</citedby><cites>FETCH-LOGICAL-c408t-8d7b0f5867a66485d887d52c5c35f4eec69e5c0dc10af118fb5fec883388f8d43</cites><orcidid>0000-0003-0857-8379 ; 0000-0003-4098-3163 ; 0000-0003-1428-9944 ; 0000-0002-8614-3904</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30670440$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fattizzo, Bruno</creatorcontrib><creatorcontrib>Zaninoni, Anna</creatorcontrib><creatorcontrib>Pettine, Loredana</creatorcontrib><creatorcontrib>Cavallaro, Francesca</creatorcontrib><creatorcontrib>Di Bona, Eros</creatorcontrib><creatorcontrib>Barcellini, Wilma</creatorcontrib><title>Low-dose rituximab in autoimmune hemolytic anemia: 10 years after</title><title>Blood</title><addtitle>Blood</addtitle><subject>Anemia, Hemolytic, Autoimmune</subject><subject>Antibodies, Monoclonal, Murine-Derived</subject><subject>Humans</subject><subject>Rituximab</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFO3DAQhi0EYpeFN6iqHLmYjh07me2hEkJAK63UC5wtxx4LV8ma2knLvj3ZLuXIaS7fzD__x9gnAVdCoPzS9Sl5LkEgF5IjainxiC2FlsgBJByzJQA0XK1bsWBnpfwCEKqW-pQtamhaUAqW7HqT_nKfClU5jtNLHGxXxW1lpzHFYZi2VD3RkPrdGF1ltzRE-7USUO3I5lLZMFI-ZyfB9oUu3uaKPd7dPtx855uf9z9urjfcKcCRo287CBqb1jaNQu0RW6-l067WQRG5Zk3agXcCbJgLhk4Hcoh1jRjQq3rFLg93n3P6PVEZzRCLo76f30pTMVK067kS1HtUHVCXUymZgnnOc7O8MwLMXp75J8_s5RkhzUHevPb5LWHqBvLvS_9tzcC3A0Bzzz-Rsiku0taRj5ncaHyKHye8At1uf-o</recordid><startdate>20190228</startdate><enddate>20190228</enddate><creator>Fattizzo, Bruno</creator><creator>Zaninoni, Anna</creator><creator>Pettine, Loredana</creator><creator>Cavallaro, Francesca</creator><creator>Di Bona, Eros</creator><creator>Barcellini, Wilma</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0857-8379</orcidid><orcidid>https://orcid.org/0000-0003-4098-3163</orcidid><orcidid>https://orcid.org/0000-0003-1428-9944</orcidid><orcidid>https://orcid.org/0000-0002-8614-3904</orcidid></search><sort><creationdate>20190228</creationdate><title>Low-dose rituximab in autoimmune hemolytic anemia: 10 years after</title><author>Fattizzo, Bruno ; Zaninoni, Anna ; Pettine, Loredana ; Cavallaro, Francesca ; Di Bona, Eros ; Barcellini, Wilma</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-8d7b0f5867a66485d887d52c5c35f4eec69e5c0dc10af118fb5fec883388f8d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Anemia, Hemolytic, Autoimmune</topic><topic>Antibodies, Monoclonal, Murine-Derived</topic><topic>Humans</topic><topic>Rituximab</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fattizzo, Bruno</creatorcontrib><creatorcontrib>Zaninoni, Anna</creatorcontrib><creatorcontrib>Pettine, Loredana</creatorcontrib><creatorcontrib>Cavallaro, Francesca</creatorcontrib><creatorcontrib>Di Bona, Eros</creatorcontrib><creatorcontrib>Barcellini, Wilma</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fattizzo, Bruno</au><au>Zaninoni, Anna</au><au>Pettine, Loredana</au><au>Cavallaro, Francesca</au><au>Di Bona, Eros</au><au>Barcellini, Wilma</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low-dose rituximab in autoimmune hemolytic anemia: 10 years after</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>2019-02-28</date><risdate>2019</risdate><volume>133</volume><issue>9</issue><spage>996</spage><epage>998</epage><pages>996-998</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>30670440</pmid><doi>10.1182/blood-2018-12-885228</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0003-0857-8379</orcidid><orcidid>https://orcid.org/0000-0003-4098-3163</orcidid><orcidid>https://orcid.org/0000-0003-1428-9944</orcidid><orcidid>https://orcid.org/0000-0002-8614-3904</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2019-02, Vol.133 (9), p.996-998
issn 0006-4971
1528-0020
language eng
recordid cdi_proquest_miscellaneous_2179440034
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Anemia, Hemolytic, Autoimmune
Antibodies, Monoclonal, Murine-Derived
Humans
Rituximab
title Low-dose rituximab in autoimmune hemolytic anemia: 10 years after
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T11%3A18%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low-dose%20rituximab%20in%20autoimmune%20hemolytic%20anemia:%2010%20years%20after&rft.jtitle=Blood&rft.au=Fattizzo,%20Bruno&rft.date=2019-02-28&rft.volume=133&rft.issue=9&rft.spage=996&rft.epage=998&rft.pages=996-998&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2018-12-885228&rft_dat=%3Cproquest_cross%3E2179440034%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2179440034&rft_id=info:pmid/30670440&rft_els_id=S0006497120427545&rfr_iscdi=true